City
Epaper

Delhi reports 84 fresh Covid cases, positivity rate rises to 5.08%

By IANS | Updated: March 22, 2023 21:20 IST

New Delhi, March 22 Delhi on Wednesday reported 84 fresh Covid infections in the last 24 hours, as ...

Open in App

New Delhi, March 22 Delhi on Wednesday reported 84 fresh Covid infections in the last 24 hours, as per the government health bulletin.

Meanwhile, the positivity rate of the city stands at 5.08 per cent. The number of active cases stands at 292 out of which 197 patients are being treated in home isolation.

With 62 patients recovering in the last 24 hours, the total number of recoveries so far has gone to 19,81,355, while Delhi's total caseload is 20,08,171 and the death toll in the city continue at 26,524.

A total of 1,653 new tests 1156 RT-PCR and 497 Rapid Antigen - were conducted in the last 24 hours, taking the total to 4,07,70,807 while 106 vaccines were administered - 16 first doses, 43 second doses, and 47 precaution doses.

The total number of cumulative beneficiaries vaccinated so far stands at 3,74,03,900 according to the health bulletin.


avr/vd

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Rapid influenza diagnostic test
Open in App

Related Stories

HealthIndia reports 40% jump in new Covid cases, Delhi govt calls emergency meet

HealthDelhi reports 300 Covid cases, positivity rate nears 14%

HealthDelhi reports 153 Covid cases, positivity rate crosses 9%

HealthDelhi reports 152 Covid cases, positivity rises nears to 7%

HealthDelhi reports 117 new Covid cases

Health Realted Stories

HealthMeditation can help find solutions to global challenges: V-P Radhakrishnan

HealthIndia’s pharmaceutical exports exceed $28 billion up to February

HealthGujarat: Hotels, eateries fined for paneer display violations; 615 kg of substandard food destroyed

HealthMinistry of Social Justice clocks highest-ever Rs 11,810 crore expenditure in FY26

HealthIndia to boost biosimilar insulin, CGM manufacturing as Global South looks for support